The Myotonic Dystrophy Type 2 Protein ZNF9 Is Part of an ITAF Complex That Promotes Cap-Independent Translation

Molecular and Cellular Proteomics - United States
doi 10.1074/mcp.m600384-mcp200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

Marathoning With Myotonic Dystrophy Type 2 (Proximal Myotonic Myopathy) and Leukopenia

SAGE Open Medical Case Reports
2017English

Myotonic Dystrophy Type 1

CMAJ
Medicine
2016English

REM Behavior Disorder in Myotonic Dystrophy Type 2

Neurology
Neurology
2012English

Anesthesia and Myotonic Dystrophy Type 2: A Case Series

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2010English

Disease Burden of Myotonic Dystrophy Type 1

Journal of Neurology
Neurology
2019English

Consensus-Based Care Recommendations for Adults With Myotonic Dystrophy Type 2

Neurology: Clinical Practice
Neurology
2019English

Cellular Cap-Binding Protein, eIF4E, Promotes Picornavirus Genome Restructuring and Translation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Renal Dysfunction Is Common in Myotonic Dystrophy

Journal of the Neurological Sciences
Neurology
2015English

Rational Design of Bioactive, Modularly Assembled Aminoglycosides Targeting the RNA That Causes Myotonic Dystrophy Type 1

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy